Thursday 22 November 2012 – UCB Pharma, Braine l'Alleud, Belgium
Preliminary Program

 

You can download this program from the pdf in attachment at the bottom of this page.

8:30-9:00
 
Coffee
 
 
9:00-9:10
 
Welcome
 

 
Morning session: Introductory lectures

9:10-10:10
 
Vaccine Regulatory Toxicology – update on
recent EMA and WHO guideline revisions
 
C. Herberts,
Medicines Evaluation Board, Nl
 
10:10-10:30
 
Coffee break

 


 
10:30-11:15 Different approaches in DART testing driven by
biopharmaceutical subclasses
 
M. Beekhuijzen,
WIL Research, Nl
11:15-12:00
 
Juvenile toxicology for biopharmaceuticals

 

P. Baldrick,
Covance, UK
 
12:00-13:00
 
Lunch and networking
 
 
Afternoon session: Case studies
(chair : J. Sims, Integrated Biologix, UK)

13:00-13:15
 
Introduction to breakout sessions A. Cauvin,
UCB Pharma, B
 
13:15-14:30 Breakout sessions
 
14:30-14:50
 
Coffee break
 
 
14:50-16:50
 
Case study reporting and discussion
 
participants
 
16:50-17:00
 
Concluding remarks
 
 
Organising Committee : Judith Baumeister (Ablynx), Annick Cauvin (UCB Pharma),
Miranda Cornet (UCB Pharma), Michaela Damsten (GSK Vaccines), 
Ilham Smyej (Johnson & Johnson), Lawrence Segal (GSK Vaccines)
with the technical assistance of Marleen Hallam (BelTox) and Catherine Vos (UCB Pharma)